We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Cardiac Tissue Ablation with HIFU Energy

By HospiMedica staff writers
Posted on 06 Jan 2005
A high-intensity focused ultrasound (HIFU) system allows an ablation device to be placed on the outside of a beating heart and deliver HIFU energy across the wall of the heart to create precise and complete lines of cardiac tissue ablation to treat atrial fibrillation (AF).

In the first case to date, the system was successfully used to treat a 71-year-old male with paroxysmal AF and co-morbid coronary artery disease. More...
The system was originally developed by Epicor Medical, which was acquired by St. Jude Medical (St. Paul, MN, USA) in June 2004. St. Jude has worked closely with Dr. James Cox, emeritus professor of surgery, Washington University School of Medicine (St. Louis, MO, USA) to develop its HIFU ablation system and the related surgical procedure. Dr. Cox is the developer of the Cox-Maze surgical procedure for the treatment of AF.

In the Cox-Maze procedure, maze-like patterns are cut in the left atrial tissue, blocking the pathways that propagate AF. The technique is nearly 90% effective but highly invasive for patients and technically challenging. The HIFU technology allows doctors to safely and effectively create a simplified maze lesion pattern through a less-invasive approach without placing patients on a cardiopulmonary bypass system and arresting their hearts.

"This technology has the potential not only to improve the cure rate for atrial fibrillation but also to increase the number of patients who can be treated for this widely prevalent disease,” commented Dr. Cox.




Related Links:
St. Jude Medical

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.